Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome
ACTIVE_NOT_RECRUITING
Status
Conditions
Interventions
- DRUG: Vericiguat Oral Tablet
Sponsor
Charite University, Berlin, Germany
Collaborators